Cooper Companies | COO - Vermögenswerte

Aktienkurs
64.42
Täglich Wechseln
-0.53 -0.82%
Monatlich
-9.84%
Jährlich
-20.36%
Q2 Prognose
63.04




Vermögenswerte Veränderung Datum
Abbott USD 86.71B 2.53B 2025-12
Align Technology USD 6.23B 141K 2025-12
AtriCure USD 654.18M 18.74M 2025-12
Avanos Medical USD 1.07B 6M 2025-12
Bausch Health Companies USD 26.37B 458M 2025-12
Baxter International USD 20.06B 1.01B 2025-12
Bayer EUR 104.54B 331M 2025-12
Becton, Dickinson and Co. USD 54.84B 484M 2025-12
Boston Scientific USD 43.67B 966M 2025-12
Cooper Companies USD 12.42B 29.4M 2025-12
Dentsply International USD 5.43B 224M 2025-12
Dexcom USD 6.34B 1.16B 2025-12
Edwards Lifesciences USD 13.7B 425M 2025-12
Globus Medical USD 5.3B 207.12M 2025-12
Haemonetics USD 2.49B 48.73M 2025-12
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.19B 161.1M 2025-12
Integra LifeSciences USD 3.6B 44.45M 2025-12
Intuitive Surgical USD 20.11B 347.7M 2026-03
J&J USD 200.89B 1.68B 2026-03
Medtronic USD 91.48B 139M 2025-12
Merit Medical Systems USD 2.69B 54.92M 2025-12
Novartis USD 110.95B 3.66B 2025-12
ResMed USD 8.5B 195.02M 2025-12
STAAR Surgical USD 451.68M 4.68M 2025-12
Steris USD 10.59B 180.7M 2025-12
Stryker USD 47.84B 787M 2025-12
Tandem Diabetes Care USD 881.11M 6.46M 2025-12
Teleflex USD 6.95B 924.7M 2025-12
Utah Medical Products USD 122.54M 567K 2025-12
Zimmer Biomet Holdings USD 23.09B 396.3M 2025-12